EPISODE · Jun 3, 2013 · 9 MIN
Should Myeloma Residual Disease Become a Standard Assay for Large Cooperative Groups and Myeloma Referral Centers?
from Journal of Clinical Oncology (JCO) Podcast
Minimal residual disease predicts outcomes in myeloma.
NOW PLAYING
Should Myeloma Residual Disease Become a Standard Assay for Large Cooperative Groups and Myeloma Referral Centers?
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m